{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:01Z","timestamp":1787026561146,"version":"build-2736575974"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Kidney transplant (KTx) recipients commonly develop transient lymphopenia due to treatment with alemtuzumab, rabbit anti-thymocyte globulin (rATG) or other conditions. However, persistent lymphopenia lasting for years has not been studied in detail. The goal of this study was to determine the prevalence of persistent lymphopenia, evaluate its association with mortality and investigate possible mechanisms by which it occurs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively studied peripheral blood lymphocyte and leukocyte counts in 7307 adult, solitary renal transplant recipients transplanted between 1\/2006 to 12\/2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      While leukocyte counts generally remained within the normal range, lymphocyte counts 3 years after KTx were below normal in 31% (compared to 14% pretransplant and 54% at 1 year). Increasing severity of lymphopenia at 3 years was associated with increasing risk of mortality. The major risk factors for lymphopenia at 3 years were: receiving alemtuzumab or rATG for induction or the treatment of rejection, increasing recipient age, pretransplant dialysis, a low lymphocyte count pretransplant, and having a prior kidney transplant. Mass cytometry immunophenotyping at 3 years showed that B cells, NK cells and all T cell subsets (CD4, CD8, na\u00efve, memory, etc.) decreased with decreasing lymphocyte counts. This included fewer recent thymic emigrants, na\u00efve T cells, and stem-cell like memory T cells (T\n                      <jats:sub>SCM<\/jats:sub>\n                      ), suggesting an impaired homeostasis of peripheral T cells. PD-1 expression was increased with decreasing lymphocyte counts in T and B cells and in most T cell subsets including CD4 T\n                      <jats:sub>SCM<\/jats:sub>\n                      , CD4 and CD8 na\u00efve cells, and CD4 recent thymic emigrants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We conclude that persistent lymphopenia might be partially due to impaired homeostatic mechanisms in T, B and NK cells and might be a simple, useful biomarker for individualizing patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1605794","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:12:06Z","timestamp":1750291926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Persistent lymphopenia after kidney transplantation: increased mortality and decreased homeostatic mechanisms"],"prefix":"10.3389","volume":"16","author":[{"given":"Yun","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelrheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma","family":"Kesik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateo Velasquez","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pavelko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambi","family":"Jarmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish K.","family":"Mour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi S.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Stegall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/txd.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management","volume":"8","author":"Mezkani","year":"2022","journal-title":"Transplant Direct"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009090976","article-title":"Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation","volume":"21","author":"Ducloux","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000048718.43419.44","article-title":"CD4 cell lymphopenia and atherosclerosis in renal transplant recipients","volume":"14","author":"Ducloux","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm1326","article-title":"Host-reactive CD8+ memory stem cells in graft-versus-host disease","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nprot.2012.143","article-title":"Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells","volume":"8","author":"Gattinoni","year":"2013","journal-title":"Nat Protoc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T cells: key to successful immunotherapy","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000629","article-title":"Increased telomere attrition after renal transplantation-impact of antimetabolite therapy","volume":"2","author":"Luttropp","year":"2016","journal-title":"Transplant Direct"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.01.040","article-title":"T-cell exhaustion correlates with improved outcomes in kidney transplant recipients","volume":"96","author":"Fribourg","year":"2019","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2018.06.006","article-title":"Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients","volume":"79","author":"Schaenman","year":"2018","journal-title":"Hum Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2024.10.034","article-title":"Physician-directed mycophenolate mofetil dose reduction after kidney transplantation: A multicenter real word experience","volume":"56","author":"Wadei","year":"2024","journal-title":"Transplant Proc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mad.2009.12.006","article-title":"Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells","volume":"131","author":"Trzonkowski","year":"2010","journal-title":"Mech Ageing Dev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124112","article-title":"Growth differentiation factor 15: A biomarker with high clinical potential in the evaluation of kidney transplant candidates","volume":"9","author":"de Cos Gomez","year":"2020","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.837575","article-title":"Growth differentiation factor-15 in immunity and aging","volume":"3","author":"Pence","year":"2022","journal-title":"Front Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clinbiochem.2019.07.013","article-title":"Growth differentiation factor 15 is decreased by kidney transplantation","volume":"73","author":"Connelly","year":"2019","journal-title":"Clin Biochem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa260","article-title":"Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality","volume":"36","author":"Chen","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133668","article-title":"The senescence-associated secretome as an indicator of age and medical risk","volume":"5","author":"Schafer","year":"2020","journal-title":"JCI Insight"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000005103","article-title":"Increased pretransplant inflammatory biomarkers predict death with function after kidney transplantation","volume":"108","author":"Lorenz","year":"2024","journal-title":"Transplantation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.240531","article-title":"Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey","volume":"61","author":"Adeli","year":"2015","journal-title":"Clin Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:12:07Z","timestamp":1750291927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1605794"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605794","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1605794"}}